An interventional study of Telemedical coaching and Telemedicine in Type 2 Diabetes Mellitus, sponsored by West German Center of Diabetes and Health. Completed at 1 site in Germany. Open to participants aged 25 Years to 79 Years. Per ClinicalTrials.gov, last updated 2016-02-23.
Sponsored by West German Center of Diabetes and Health · Not applicable, Interventional, and Supportive care
The purpose of the study is to compare the effect of telemedical coaching versus telemedical control on HbA1c, weight, BMI, blood pressure, blood lipids, medication, nutrition, physical activity and quality of life in type 2 diabetes patients with poor glycaemic control.
10,925 studies on the registry are indexed under Diabetes Mellitus; 1,318 are open to participants now.
This study's enrollment of 202 is above the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.
Browse Diabetes Mellitus studies →West German Center of Diabetes and Health is the lead sponsor of 18 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients will receive telemedical devices i.e. for the measurement of blood glucose, weight and physical activity. These devices will transfer the data to a data collector with a SIM card which sends the data to a data portal, which can be monitored by the participant and the coach. Health coaches which will have close phone contact to patients, supporting them to reduce weight and increase physical activity. In the first 12 weeks, patients will follow a formula diet (Almased) to achieve an initial weight reduction.
Behavioral: Telemedical coaching · Other: Telemedicine
Patients will receive telemedical devices i.e. for the measurement of blood glucose, weight and physical activity. These devices will transfer the data to a data collector with a SIM card which sends the data to a data portal which can be monitored by the participant.
Behavioral: Telemedical coaching
HbA1c
Difference in HbA1c (at end of study vs. baseline) between the groups
Time frame: 12 months
weight
Difference in weight (at end of study vs. baseline) between the groups
Time frame: 12 months
antidiabetic medication
Difference in antidiabetic medication (at end of study vs. baseline) between the groups
Time frame: 12 months
Cardiovascular risk parameters (blood pressure, blood lipids)
Difference in cardiovascular risk parameters (i.e. blood pressure, blood lipids) (at end of study vs. baseline) between the groups
Time frame: 12 months
physical activity (step count)
Difference in physical activity (at end of study vs. baseline) between the groups
Time frame: 12 months
nutrition
Difference in nutrition (at end of study vs. baseline) between the groups
Time frame: 12 months
quality of life
Difference in quality of life (at end of study vs. baseline) between the groups
Time frame: 12 months
This study is completed, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
West German Center of Diabetes and Health